199 related articles for article (PubMed ID: 15499116)
1. The PROGRESS trial three years later: time for a balanced report of effectiveness.
Wennberg R; Zimmermann C
BMJ; 2004 Oct; 329(7472):968-70. PubMed ID: 15499116
[TBL] [Abstract][Full Text] [Related]
2. The PROGRESS trial three years later: time for more action, less distraction.
Macmahon S; Neal B; Rodgers A; Chalmers J
BMJ; 2004 Oct; 329(7472):970-1. PubMed ID: 15499117
[No Abstract] [Full Text] [Related]
3. [Efficacy of a converting enzyme inhibitor in the prevention of recurrence of stroke].
Masson C
Presse Med; 2001 Nov; 30(35):1716-7. PubMed ID: 11775593
[No Abstract] [Full Text] [Related]
4. [Clinical efficacy of noliprel in the treatment of hypertension. Main results of ETALON].
Oganov RG; Nebieridze DV
Kardiologiia; 2004; 44(3):66-9. PubMed ID: 15489830
[No Abstract] [Full Text] [Related]
5. Combination BP therapy cuts second stroke risk in half.
Geriatrics; 2001 Aug; 56(8):14, 16. PubMed ID: 11505852
[No Abstract] [Full Text] [Related]
6. Invited commentary. Stroke preventive treatment using perindopril and indapamide in the context of Indian primary care.
Wennberg RA; Zimmermann C
Neurol India; 2007; 55(2):101-2. PubMed ID: 17558107
[No Abstract] [Full Text] [Related]
7. Incidence of recurrent stroke in primary care during preventive treatment based on perindopril with or without indapamide.
Padma MV; Kaul S
Neurol India; 2007; 55(2):141-4. PubMed ID: 17558118
[TBL] [Abstract][Full Text] [Related]
8. You should treat patients over the age of 80 who have hypertension.
Lundberg GD
Medscape J Med; 2008; 10(8):185. PubMed ID: 18924637
[No Abstract] [Full Text] [Related]
9. Blood pressure reduction and ACE inhibition in secondary stroke prevention: mechanism uncertain.
Davis SM; Donnan GA
Stroke; 2003 May; 34(5):1335-6. PubMed ID: 12702835
[No Abstract] [Full Text] [Related]
10. Effects of a perindopril-based blood pressure-lowering regimen on the risk of recurrent stroke according to stroke subtype and medical history: the PROGRESS Trial.
Chapman N; Huxley R; Anderson C; Bousser MG; Chalmers J; Colman S; Davis S; Donnan G; MacMahon S; Neal B; Warlow C; Woodward M;
Stroke; 2004 Jan; 35(1):116-21. PubMed ID: 14671247
[TBL] [Abstract][Full Text] [Related]
11. Blood pressure-lowering for secondary prevention of stroke: ACE inhibition is not the key.
Bath P
Stroke; 2003 May; 34(5):1334-5. PubMed ID: 12702833
[No Abstract] [Full Text] [Related]
12. [Type 2 diabetes. Routine ACE inhibitors?].
Hönl SB
Med Monatsschr Pharm; 2008 Apr; 31(4):149-50. PubMed ID: 18497249
[No Abstract] [Full Text] [Related]
13. The PROGRESS trial three years later: HOPE trial may shed some light.
Attia J; D'Este C; Levi CR
BMJ; 2004 Dec; 329(7479):1403-4. PubMed ID: 15591574
[No Abstract] [Full Text] [Related]
14. Blood pressure and stroke; the PROGRESS trial.
He FJ; MacGregor GA
J Renin Angiotensin Aldosterone Syst; 2001 Sep; 2(3):153-5. PubMed ID: 11881116
[No Abstract] [Full Text] [Related]
15. Stroke prevention: indapamide, a forgotten option?
Parra Ruiz J; Muñoz Medina L; Miras Parra F; de la Higuera Torres-Puchol JM
Stroke; 2003 Sep; 34(9):e156-7; author reply e156-7. PubMed ID: 12947159
[No Abstract] [Full Text] [Related]
16. Secondary prevention for stroke and transient ischaemic attacks.
Muir KW
BMJ; 2004 Feb; 328(7435):297-8. PubMed ID: 14764462
[No Abstract] [Full Text] [Related]
17. [Cerebrovascular disease: Impact of INDANA meta-analysis and PROGRESS trial].
Matsumoto M
Nihon Rinsho; 2004 Mar; 62 Suppl 3():605-11. PubMed ID: 15179938
[No Abstract] [Full Text] [Related]
18. [Treatment of hypertension in patients older than 80 years].
Rump LC; Nitschmann S
Internist (Berl); 2009 Sep; 50(9):1169-70. PubMed ID: 19690822
[No Abstract] [Full Text] [Related]
19. [PROGRESS].
Hasegawa Y
Nihon Rinsho; 2006 Aug; 64 Suppl 6():396-401. PubMed ID: 16983776
[No Abstract] [Full Text] [Related]
20. The PROGRESS trial: questions about the effectiveness of angiotensin converting enzyme inhibitors. Perindopril pROtection aGainst REcurrent Stroke Study.
Psaty BM; Weiss NS; Furberg CD
Am J Hypertens; 2002 May; 15(5):472-4. PubMed ID: 12022252
[No Abstract] [Full Text] [Related]
[Next] [New Search]
